Icecure Net Tangible Assets from 2010 to 2024

ICCM Stock  USD 0.83  0.02  2.47%   
Icecure Medical Net Tangible Assets yearly trend continues to be very stable with very little volatility. Net Tangible Assets are likely to drop to about 16.1 M. Net Tangible Assets is the total assets of Icecure Medical minus any intangible assets such as patents, copyrights, and goodwill; it represents the physical assets of a company. View All Fundamentals
 
Net Tangible Assets  
First Reported
2010-12-31
Previous Quarter
29.2 M
Current Value
16.1 M
Quarterly Volatility
11.6 M
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Icecure Medical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Icecure Medical's main balance sheet or income statement drivers, such as Depreciation And Amortization of 339.1 K, Interest Expense of 120.2 K or Selling General Administrative of 2.4 M, as well as many indicators such as Price To Sales Ratio of 14.37, Dividend Yield of 0.0 or PTB Ratio of 4.22. Icecure financial statements analysis is a perfect complement when working with Icecure Medical Valuation or Volatility modules.
  
Check out the analysis of Icecure Medical Correlation against competitors.
To learn how to invest in Icecure Stock, please use our How to Invest in Icecure Medical guide.

Latest Icecure Medical's Net Tangible Assets Growth Pattern

Below is the plot of the Net Tangible Assets of Icecure Medical over the last few years. It is the total assets of a company minus any intangible assets such as patents, copyrights, and goodwill; it represents the physical assets of a company. Icecure Medical's Net Tangible Assets historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Icecure Medical's overall financial position and show how it may be relating to other accounts over time.
Net Tangible Assets10 Years Trend
Slightly volatile
   Net Tangible Assets   
       Timeline  

Icecure Net Tangible Assets Regression Statistics

Arithmetic Mean8,474,351
Geometric Mean3,601,148
Coefficient Of Variation136.66
Mean Deviation9,991,841
Median(893,000)
Standard Deviation11,581,419
Sample Variance134.1T
Range30.1M
R-Value0.86
Mean Square Error37.7T
R-Squared0.74
Significance0.00004
Slope2,226,313
Total Sum of Squares1877.8T

Icecure Net Tangible Assets History

202416.1 M
202329.2 M
202225.4 M
202127 M
202014.7 M
20199.1 M
201812.7 M

About Icecure Medical Financial Statements

Icecure Medical investors utilize fundamental indicators, such as Net Tangible Assets, to predict how Icecure Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Last ReportedProjected for Next Year
Net Tangible Assets29.2 M16.1 M

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether Icecure Medical is a strong investment it is important to analyze Icecure Medical's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Icecure Medical's future performance. For an informed investment choice regarding Icecure Stock, refer to the following important reports:
Check out the analysis of Icecure Medical Correlation against competitors.
To learn how to invest in Icecure Stock, please use our How to Invest in Icecure Medical guide.
You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Icecure Medical. If investors know Icecure will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Icecure Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.28)
Revenue Per Share
0.071
Quarterly Revenue Growth
0.079
Return On Assets
(0.47)
Return On Equity
(0.94)
The market value of Icecure Medical is measured differently than its book value, which is the value of Icecure that is recorded on the company's balance sheet. Investors also form their own opinion of Icecure Medical's value that differs from its market value or its book value, called intrinsic value, which is Icecure Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Icecure Medical's market value can be influenced by many factors that don't directly affect Icecure Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Icecure Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Icecure Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Icecure Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.